ENTA Stock-Based Compensation
Enanta Pharmaceuticals Inc · Stock-Based Compensation
ENTA Stock-Based Compensation
Latest reported$15.28Mperiod ending
ENTA Stock-Based Comp ($259.00K → $15.28M)
Annual stock-based compensation
High-resolution chart · PNG
ENTA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 18,565,000 | |
| 26,795,000 | |
| 28,216,000 | |
| 26,969,000 | |
| 20,991,000 | |
| 19,575,000 | |
| 19,226,000 | |
| 15,845,000 | |
| 13,071,000 | |
| 9,354,000 | |
| 5,838,000 | |
| 2,682,000 | |
| 1,063,000 | |
| 424,000 | |
| 225,000 | |
| 259,000 |